Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VH7

Crystal structure of heparosan synthase 2 from Pasteurella multocida at 1.98 A

8VH7 の概要
エントリーDOI10.2210/pdb8vh7/pdb
分子名称Heparosan synthase B, MANGANESE (II) ION, URIDINE-5'-DIPHOSPHATE, ... (6 entities in total)
機能のキーワードglycosyltransferase, heparosan, chemoenzymatic synthesis, heparan sulfate, transferase
由来する生物種Pasteurella multocida
タンパク質・核酸の鎖数2
化学式量合計130001.55
構造登録者
Pedersen, L.C.,Liu, J.,Stancanelli, E.,Krahn, J.M. (登録日: 2023-12-31, 公開日: 2024-07-24, 最終更新日: 2025-03-12)
主引用文献Stancanelli, E.,Krahn, J.A.,Viverette, E.,Dutcher, R.,Pagadala, V.,Borgnia, M.J.,Liu, J.,Pedersen, L.C.
Structural and Functional Analysis of Heparosan Synthase 2 from Pasteurella multocida (PmHS2) to Improve the Synthesis of Heparin.
Acs Catalysis, 14:6577-6588, 2024
Cited by
PubMed Abstract: Heparin is a widely used drug to treat thrombotic disorders in hospitals. Heparosan synthase 2 from (PmHS2) is a key enzyme used for the chemoenzymatic synthesis of heparin oligosaccharides. It has both activities: glucosaminyl transferase activity and glucuronyl transferase activity; however, the mechanism to carry out the glyco-oligomerization is unknown. Here, we report crystal structures of PmHS2 constructs with bound uridine diphosphate (UDP) and a cryo-EM structure of PmHS2 in complex with UDP and a heptasaccharide (NS 7-mer) substrate. Using a LC-MC analytical method, we discovered the enzyme displays both a two-step concerted oligomerization mode and a distributive oligomerization mode depending on the non-reducing end of the starting oligosaccharide primer. Removal of 7 amino acid residues from the C-terminus results in an enzymatically active monomer instead of dimer and loses the concerted oligomerization mode of activity. In addition, the monomer construct can transfer N-acetyl glucosamine at a substrate concentration that is ∼7-fold higher than wildtype enzyme. It was also determined that an F529A mutant can transfer an N-sulfo glucosamine (GlcNS) saccharide from a previously inactive UDP-GlcNS donor. Performing the glyco-transfer reaction at a high substrate concentration and the capability of using unnatural donors are desirable to simplify the chemoenzymatic synthesis to prepare heparin-based therapeutics.
PubMed: 39990868
DOI: 10.1021/acscatal.4c00677
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.982 Å)
構造検証レポート
Validation report summary of 8vh7
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon